Terms: = Cervical cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Prognosis
3 results:
1. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
Rocha Martins P; Luciano Pereira Morais K; de Lima Galdino NA; Jacauna A; Paula SOC; Magalhães WCS; Zuccherato LW; Campos LS; Salles PGO; Gollob KJ
Sci Rep; 2023 Dec; 13(1):22634. PubMed ID: 38114557
[TBL] [Abstract] [Full Text] [Related]
2. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Fiano V; Trevisan M; Fasanelli F; Grasso C; Marabese F; da Graça Bicalho M; de Carvalho NS; Maestri CA; Merletti F; Sacerdote C; De Marco L; Gillio-Tos A
Gynecol Oncol; 2018 Nov; 151(2):319-326. PubMed ID: 30172480
[TBL] [Abstract] [Full Text] [Related]
3. Genomic organization of human papillomavirus type 18 in cervical cancer specimens.
Kitagawa K; Yoshikawa H; Onda T; Kawana T; Taketani Y; Yoshikura H; Iwamoto A
Jpn J Cancer Res; 1996 Mar; 87(3):263-8. PubMed ID: 8613428
[TBL] [Abstract] [Full Text] [Related]